Interaction Between Glycosaminoglycans, Platelets, and Leukocytes

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  1994-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-2007-1001909PMID 7824958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparin associated thrombocytopenia.

  1995cited by this paper
• Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity.

  1993cited by this paper
• Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions.

  1993cited by this paper
• Therapeutic Effect of a Low Molecular Weight Dermatan Sulphate (Desmin 370) in Rat Venous Thrombosis - Evidence for an Anticoagulant-Independent Mechanism

  1993cited by this paper
• Intracellular Ca2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G.

  1992cited by this paper
• Heparin inhibits neutrophil-induced platelet activation via cathepsin G.

  1992cited by this paper
• Specific binding between human neutrophils and heparin

  1992cited by this paper
• Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G.

  1992cited by this paper
• Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers.

  1991cited by this paper
• Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.

  1991cited by this paper
• Cathepsin G binding to human platelets. Evidence for a specific receptor.

  1990cited by this paper
• Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.

  1990cited by this paper
• Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.

  1990cited by this paper
• Platelet‐dependent induction and amplification of polymorphonuclear leucocyte lysosomal enzyme release

  1989cited by this paper
• Partially N-desulfated heparin as a non-anticoagulant heparin: some physico-chemical and biological properties.

  1989cited by this paper
• Neutrophil function in ischemic heart disease.

  1989cited by this paper
• Heparin binding to resting and activated platelets.

  1989cited by this paper
• Effects of Glycosaminoglycans and Protamine Chloridrate on Platelet Aggregation Induced by Collagen and Thrombin

  1989cited by this paper
• Neutrophil cathepsin G increases transendothelial albumin flux.

  1989cited by this paper
• Tissue destruction by neutrophils.

  1989cited by this paper
• Cathepsin G is a strong platelet agonist released by neutrophils.

  1988cited by this paper
• Heparin binding to normal and abnormal platelets.

  1988cited by this paper
• White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin

  1988cited by this paper
• Neutrophil cathepsin G increases permeability of cultured type II pneumocytes.

  1988cited by this paper
• Characterization of platelet binding of heparins and other glycosaminoglycans.

  1988cited by this paper
• Inhibition of leucocyte elastase by heparin and its derivatives.

  1988cited by this paper
• Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)

  1987cited by this paper
• ANTITHROMBOTIC ACTIVITY OF A SYNTHETIC HEPARIN PENTASACCHARIDE IN A RABBIT STASIS THROMBOSIS MODEL USING DIFFERENT THROMBOGENIC CHALLENGES

  1987cited by this paper
• EFFECT OF COLLAGEN AND CITRATE ON HEPARIN-HEDIATED PLATELET ANTIAGGREGATORY ACTIVITY

  1987cited by this paper
• Leukocytes and the risk of ischemic diseases.

  1987cited by this paper
• Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia.

  1986cited by this paper
• Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).

  1986cited by this paper
• Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes.

  1986cited by this paper
• Structure and biological activity of heparin.

  1985cited by this paper
• Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damage.

  1984cited by this paper
• Effect of heparin on platelet aggregation

  1984cited by this paper
• Heparin-associated thrombocytopenia.

  1984cited by this paper
• Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.

  1984cited by this paper
• Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.

  1983cited by this paper
• Glycosaminoglycans in human neutrophils and leukemic myeloblasts: ultrastructural, cytochemical, immunologic, and biochemical characterization.

  1983cited by this paper
• Effect of Neutral Proteases from Blood Leukocytes on Human Platelets

  1983cited by this paper
• Heparin Counteracts the Antiaggregating Effect of Prostacyclin by Potentiating Platelet Aggregation

  1983cited by this paper
• Interaction of the chymotrypsin- and elastase-like enzymes of the human granulocyte with glycosaminoglycans.

  1981cited by this paper
• Inhibition of human elastase from polymorphonuclear leucocytes by a glycosaminoglycan polysulfate (Arteparon).

  1980cited by this paper
• Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

  1979cited by this paper
• Effect of heparin and thrombin on platelet adherence to the surface of rabbit aorta.

  1978cited by this paper
• The influence of the type of sulphate bond and degree of sulphation of glycosaminoglycans on their interaction with lysosomal enzymes.

  1978cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• Scanning electron microscopic observations of the common carotid artery of the rat. III. Heparin effect on platelets.

  1976cited by this paper
• Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients.

  1976cited by this paper
• Effect of heparin on platelets.

  1972cited by this paper
• The effect of heparin on the sticking of white cells to endothelium in inflammation.

  1962cited by this paper

• Sulodexide protected the heart against ischemia/reperfusion injury by reducing oxidative stress, inflammation, and apoptosis in the isolated rat heart.

  2026cites this paper
• Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion

  2024cites this paper
• Effects of different routes of administration and doses of Sulodexide on leukocyte-endothelium interaction and tissue perfusion on an animal model of low flow and high pressure in veins

  2022cites this paper
• Возможности оптимизации подготовки к беременности при наличии состояний, сопровождающихся эндотелиальной дисфункцией

  2020cites this paper
• Possibilities of optimization of pregnancy preparation in the presence of conditions accompanied by endothelial dysfunction

  2020cites this paper
• Effectiveness and safety of sulodexide in the treatment of venous diseases

  2019influential citation
• Sulodexide in venous disease

  2018cites this paper
• Hemodynamic Considerations in the Pathophysiology of Peripheral Neuropathy

  2018cites this paper
• Role of sulodexide in the treatment of CVD.

  2014cites this paper
• Development and use of sulodexide in vascular diseases: implications for treatment

  2013cites this paper
• Sulodexide: Review of recent clinical efficacy data

  2013cites this paper
• Development and use of sulodexide in vascular diseases: implications for treatment

  2013cites this paper
• Sulodexide: a renewed interest in this glycosaminoglycan.

  2006cites this paper
• Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease

  2004cites this paper
• Attenuates Myocardial Ischemia / Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis

  2004cites this paper
• Oral erosive/ulcerative lichen planus: preliminary findings in an open trial of sulodexide compared with cyclosporine (ciclosporin) therapy

  2003cites this paper
• N-desulfated heparin improves concanavalin A-induced liver injury partly through inhibiting T lymphocyte adhesion

  2003cites this paper
• Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence.

  2002cites this paper
• Improved Cancer Mortality with Low-Molecular-Weight Heparin Treatment: A Review of the Evidence

  2002cites this paper
• THE INTERACTION OF POLYSACCHARIDES WITH A SPECTROSCOPIC PROBE: THE ANION EFFECT ON THE BINDING SITE OF HEPARIN

  2001cites this paper
• The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy

  2001cites this paper
• Changes in Glycoprotein Expression after Platelet Activation: Differences between In Vitro and In Vivo Studies

  2000cites this paper
• Treatment of concanavalin A-induced hepatitis in mice with low molecular weight heparin.

  1999cites this paper
• Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

  1999cites this paper
• Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells.

  1999cites this paper
• Heparin and Cancer

  1998cites this paper
• Oxidative stress induced by bloodless limb surgery on humans

  1997cites this paper
• VASCULAR DEMENTIA ITALIAN SULODEXIDE STUDY ( VA

  1997cites this paper
• Human Platelet Morphology/Ultrastructure

  1997cites this paper
• Inflammatory bowel disease: potential therapeutic strategies.

  1997cites this paper
• Vascular dementia Italian sulodexide study (VA.D.I.S.S.). Clinical and biological results.

  1997cites this paper
• Heparin Inhibits Leukocyte Rolling in Pial Vessels and Attenuates Inflammatory Changes in a Rat Model of Experimental Bacterial Meningitis

  1997cites this paper
• Review article: platelets in inflammatory bowel disease— pathogenetic role and therapeutic implications

  1997cites this paper
• Actions of heparin in the atherosclerotic process.

  1996cites this paper
• Therapeutic uses of heparin beyond its traditional role as an anticoagulant.

  1995cites this paper